| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | myHome |
| Orderbuch | Realtime Stuttgart | Fundamentalanalyse | Insidertrades | Fonds | Senden | |
| Historisch | Realtime Push | myNews | Ausblick | im Forum | Anleihen | |
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| S&P Equity Research | 265,00CHF | +3,11% | 17.05.13 | |||
| Société Générale Group S.A. (SG) | 301,00CHF | +17,12% | 16.05.13 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 270,00CHF | +5,06% | 15.05.13 | |||
| Deutsche Bank AG | 255,00CHF | -0,78% | 13.05.13 | |||
| Morgan Stanley | 292,00CHF | +13,62% | 10.05.13 | |||
| Jefferies & Company Inc. | 255,00CHF | -0,78% | 18.04.13 | |||
| Exane-BNP Paribas SA | 225,00CHF | -12,45% | 12.04.13 | |||
| UBS AG | 217,00CHF | -15,56% | 12.04.13 | |||
| Independent Research GmbH | 236,00CHF | -8,17% | 11.04.13 | |||
| Cheuvreux SA | 220,00CHF | -14,40% | 10.04.13 | |||
| Kepler Equities, Inc. | 225,00CHF | -12,45% | 21.02.13 | |||
| Goldman Sachs Group Inc. | 245,00CHF | -4,67% | 28.01.13 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca plc | 1 | 10 | 5 | 29,37 £ | - |
| Gilead Sciences Inc. | 10 | 2 | 0 | 80,88 $ | +43,38% |
| Merck Co. | 2 | 1 | 1 | 48,00 $ | +1,42% |
| Merck KGaA | 2 | 13 | 6 | 109,42 € | -10,49% |
| Novartis AG | 9 | 9 | 2 | 68,22 | - |
| Pfizer Inc. | 7 | 4 | 1 | 28,63 $ | -0,52% |
| Roche Holding AG (Genussschein) | 9 | 3 | 0 | 250,50 | - |
| STADA Arzneimittel AG (vink. NA) | 8 | 7 | 2 | 30,01 € | -11,61% |